Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.

RATIONALE Pseudomonas aeruginosa, a major problem pathogen responsible for severe infections in critically ill patients, triggers, through a functional type-3 secretion system (T3SS), the activation of an intracellular cytosolic sensor of innate immunity, NLRC4. Although the NLRC4-inflammasome-dependent response contributes to increased clearance of intracellular pathogens, it seems that NLRC4 inflammasome activation decreases the clearance of P. aeruginosa, a mainly extracellular pathogen. OBJECTIVES We sought to determine the underlying mechanisms of this effect of the activation of NLRC4 by P. aeruginosa. METHODS We established acute lung injury in wild-type and Nlrc4(-/-) mice using sublethal intranasal inocula of P. aeruginosa strain CHA expressing or not a functional T3SS. We studied 96-hour survival, lung injury, bacterial clearance from the lungs, cytokine secretion in bronchoalveolar lavage, lung antimicrobial peptide expression by quantitative polymerase chain reaction, and flow cytometry analysis of lung cells. MEASUREMENTS AND MAIN RESULTS Nlrc4(-/-) mice showed enhanced bacterial clearance and decreased lung injury contributing to increased survival against extracellular P. aeruginosa strain expressing a functional T3SS. The mechanism involved decreased NLRC4-inflammasome-driven IL-18 secretion attenuating lung injury caused by excessive neutrophil recruitment. Additionally, in the lungs of Nlrc4(-/-) mice secretion of IL-17 by innate immune cells was increased and responsible for increased expression of lung epithelial antimicrobial peptides. Furthermore, IL-18 secretion was found to repress IL-17 and IL-17-driven lung antimicrobial peptide expression. CONCLUSIONS We report a new role of the T3SS apparatus itself, independently of exotoxin translocation. Through NLRC4 inflammasome activation, the T3SS promotes IL-18 secretion, which dampens a beneficial IL-17-mediated antimicrobial host response.

[1]  A. Prince,et al.  Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia. , 2013, The Journal of clinical investigation.

[2]  S. Lory,et al.  Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia. , 2012, American journal of respiratory and critical care medicine.

[3]  R. Zemans,et al.  Role of chemokines in the pathogenesis of acute lung injury. , 2012, American journal of respiratory cell and molecular biology.

[4]  E. Chilvers,et al.  Acute lung injury results from failure of neutrophil de‐priming: a new hypothesis , 2012, European journal of clinical investigation.

[5]  V. Dixit,et al.  Phosphorylation of NLRC4 is critical for inflammasome activation , 2012, Nature.

[6]  A. Mebazaa,et al.  Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: A randomized,double-blind, placebo-controlled trial* , 2012, Critical care medicine.

[7]  J. Kolls,et al.  Host defenses against bacterial lower respiratory tract infection. , 2012, Current opinion in immunology.

[8]  S. Ryter,et al.  Inflammasome-regulated cytokines are critical mediators of acute lung injury. , 2012, American journal of respiratory and critical care medicine.

[9]  J. Ortonne,et al.  Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. , 2012, The New England journal of medicine.

[10]  A. Zychlinsky,et al.  Neutrophil function: from mechanisms to disease. , 2012, Annual review of immunology.

[11]  N. Pujol,et al.  The Pseudokinase NIPI-4 Is a Novel Regulator of Antimicrobial Peptide Gene Expression , 2012, PloS one.

[12]  J. Kolls,et al.  Interleukin-23-Mediated Inflammation in Pseudomonas aeruginosa Pulmonary Infection , 2011, Infection and Immunity.

[13]  B. Cookson,et al.  Coordinated Host Responses during Pyroptosis: Caspase-1–Dependent Lysosome Exocytosis and Inflammatory Cytokine Maturation , 2011, The Journal of Immunology.

[14]  J. Sauer,et al.  Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity , 2011, Proceedings of the National Academy of Sciences.

[15]  R. Homer,et al.  Airway Epithelial MyD88 Restores Control of Pseudomonas aeruginosa Murine Infection via an IL-1–Dependent Pathway , 2011, The Journal of Immunology.

[16]  C. L. Lindestam Arlehamn,et al.  Pseudomonas aeruginosa pilin activates the inflammasome , 2011, Cellular microbiology.

[17]  R. Medzhitov,et al.  Pyroptosis: Macrophage Suicide Exposes Hidden Invaders , 2011, Current Biology.

[18]  S. Batra,et al.  Mechanisms of neutrophil accumulation in the lungs against bacteria. , 2010, American journal of respiratory cell and molecular biology.

[19]  K. Hartshorn,et al.  Review: Defensins and cathelicidins in lung immunity , 2010, Innate immunity.

[20]  Eduardo Guaní-Guerra,et al.  Antimicrobial peptides: general overview and clinical implications in human health and disease. , 2010, Clinical immunology.

[21]  Richard Bonneau,et al.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome , 2010, Proceedings of the National Academy of Sciences.

[22]  K. Hartshorn,et al.  Human defensins and LL‐37 in mucosal immunity , 2009, Journal of leukocyte biology.

[23]  A. Hauser.  The type III secretion system of Pseudomonas aeruginosa: infection by injection , 2009, Nature Reviews Microbiology.

[24]  Sergio Grinstein,et al.  Antimicrobial mechanisms of phagocytes and bacterial evasion strategies , 2009, Nature Reviews Microbiology.

[25]  G. Lagoumintzis,et al.  Synergistic regulation of Pseudomonas aeruginosa‐induced cytokine production in human monocytes by mannose receptor and TLR2 , 2009, European journal of immunology.

[26]  K. Faure,et al.  FITC-ALBUMIN AS A MARKER FOR ASSESSMENT OF ENDOTHELIAL PERMEABILITY IN MICE: COMPARISON WITH125I-ALBUMIN , 2009, Experimental lung research.

[27]  J. Kolls,et al.  Th17 cytokines and mucosal immunity , 2008, Immunological reviews.

[28]  R. Ramphal,et al.  Control of Pseudomonas aeruginosa in the Lung Requires the Recognition of Either Lipopolysaccharide or Flagellin1 , 2008, The Journal of Immunology.

[29]  C. Gabay,et al.  IL‐1, IL‐18, and IL‐33 families of cytokines , 2008, Immunological reviews.

[30]  N. Suttorp,et al.  NAIP and Ipaf Control Legionella pneumophila Replication in Human Cells1 , 2008, The Journal of Immunology.

[31]  L. Kuhn,et al.  Orf1/SpcS chaperones ExoS for type three secretion by Pseudomonas aeruginosa. , 2008, Biomedical and environmental sciences : BES.

[32]  L. Fouser,et al.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.

[33]  P. Gosset,et al.  Alveolar Response to Pseudomonas aeruginosa: Role of the Type III Secretion System , 2005, Infection and Immunity.

[34]  A. Dessen,et al.  The V Antigen of Pseudomonas aeruginosa Is Required for Assembly of the Functional PopB/PopD Translocation Pore in Host Cell Membranes , 2004, Infection and Immunity.

[35]  S. Akira,et al.  Interleukin-18 Impairs the Pulmonary Host Response to Pseudomonas aeruginosa , 2003, Infection and Immunity.

[36]  J. Rello,et al.  Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. , 2002, Critical care medicine.

[37]  J. Wiener-Kronish,et al.  Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury , 1999, Nature Medicine.

[38]  G. Zimmerman,et al.  The acute respiratory distress syndrome. , 1996, The Journal of clinical investigation.

[39]  P. Vignais,et al.  Pseudomonas aeruginosa contains an IHF-like protein that binds to the algD promoter. , 1993, Biochemical and biophysical research communications.

[40]  K. Huang,et al.  Phosphorylation of magainin‐2 by protein kinase C and inhibition of protein kinase C isozymes by a synthetic analogue of magainin‐2‐amide , 1990, FEBS letters.

[41]  T. Ogura,et al.  [Role of alveolar macrophages and neutrophils in the defense system against infection of Pseudomonas aeruginosa in the respiratory tract and the effect of derivative of muramyl dipeptide]. , 1990, Nihon Kyobu Shikkan Gakkai zasshi.

[42]  F. Sutterwala,et al.  NLRC4/IPAF: a CARD carrying member of the NLR family. , 2009, Clinical immunology.

[43]  Yongwon Choi,et al.  An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells , 2004, Nature Immunology.